CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer
This study has been completed.
Sponsor:
AstraZeneca
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00075192
First received: January 5, 2004
Last updated: June 5, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2006 |
| Estimated Primary Completion Date: | No date given |